‘Marty Supreme’ Becomes A24’s Highest Grossing Film at Global Box Office

Josh Safdie and Timothée Chalamet’s Marty Supreme has reached $148.8M worldwide ($92.8M domestic, $56M international), surpassing A24’s prior global record of $142M set by Everything Everywhere All at Once. The film has posted particularly strong results in the U.K. ($21M) and set an A24 record in Australia ($5.4M), with Italy at $4.8M and Mexico $3M; further releases including China (Mar. 20) and multiple Asian markets are pending around the Academy Awards. The performance underscores elevated global demand and the financial upside from a high-profile awards campaign and international rollout, reinforcing A24’s revenue momentum and franchise value even as box office upside remains concentrated in a limited slate.

Analysis

Market structure: A24’s $148.8m global haul ($92.8m US, $56m intl; UK $21m) shows awards-driven, talent-led indies can capture premium screens and outsized per-screen economics. Immediate beneficiaries are premium-format exhibitors (IMAX) and domestic chains with strong concession/ad mixes (AMC, CNK) plus OOH/movie-ad sellers; streaming aggregators lose short-term pricing power on exclusive theatrical windows. Cross-asset: expect modest tightening in high-yield spreads for highly-levered exhibitors (basis points move, not material to IG), elevated options IV on exhibitor tickers into Oscars (Mar 15) and China release (Mar 20), and negligible FX/commodity impact.

Risk assessment: Tail risks include Oscar snub (Mar 15) or China underperformance (release Mar 20) causing a 20–50% downside swing in exhibitor sentiment, pandemic/regulatory shocks, or piracy/black-market leakage compressing box office. Timeframes: immediate (days around Oscars), short-term (2–8 weeks for China and wider rollout), long-term (quarters if theatrical window economics permanently shift). Hidden dependencies: A24’s backend streaming/licensing auctions and distribution splits determine producer vs exhibitor economics — a streaming rights sale could reallocate value away from cinemas.

Trade implications: Tactical longs on IMAX (premium-format capture) and selective exposure to US exhibitors (AMC, CNK) are highest-conviction for 1–3 month event trades; use call spreads to limit cash outlay. Pair trades: long exhibitor/OOH names vs short pure-play streamers (NFLX) for 1–3 months around rights-auction and Oscars; options calendars can monetize elevated IV pre- and post-Oscars. Rotate modestly into Consumer Discretionary experiential businesses and away from subscription-levered streaming over the next 1–3 quarters.

Key Decisions for Investors

• Establish a 1.0–1.5% position in IMAX (IMAX) via a 3-month call spread (buy 15% OTM, sell 30% OTM) expiring ~June 2026 to target a 20–40% upside from a successful Oscars/China lift; exit or re-evaluate 1 week after China release (post-Mar 20) or if spread premium drops 50%.
• Establish a 0.5–1.0% tactical long in AMC Entertainment (AMC) sized for volatility; hedge by selling 30-day covered calls and set a hard stop-loss at -30% and take-profit trim at +60%; horizon 1–3 months to capture post-Oscar concession/ad tailwinds.
• Implement a pair trade: long 1.0% Cinemark (CNK) or OUTFRONT (OUT) vs short 0.5% Netflix (NFLX) for 1–3 months targeting relative outperformance of 10–20%; unwind after streaming-rights auction outcomes or by April 30 if no material rerating.
• Trim 2–4% net exposure to pure-play streaming names (NFLX, WBD, DIS content-heavy) over next 30–60 days ahead of potential rights-auction repricing; redeploy proceeds into experiential consumer (IMAX/CNK/OUT) or cash if Oscars/China outcomes are adverse.